Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Daisy Alapat

Concepts (252)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
30
2025
3049
1.920
Why?
Flow Cytometry
5
2018
478
0.850
Why?
Immunoglobulins
2
2018
76
0.680
Why?
Plasma Cells
3
2025
239
0.650
Why?
Immunoglobulin kappa-Chains
2
2016
22
0.610
Why?
Bone Marrow
7
2022
364
0.570
Why?
Monoclonal Gammopathy of Undetermined Significance
4
2025
125
0.570
Why?
DNA, Neoplasm
1
2018
146
0.550
Why?
Hematopoietic Stem Cell Transplantation
4
2024
603
0.520
Why?
Lymphoma, Large B-Cell, Diffuse
2
2015
106
0.520
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
2
2016
59
0.490
Why?
Immunoglobulin lambda-Chains
1
2015
15
0.480
Why?
Neoplasm, Residual
6
2025
173
0.480
Why?
Gene Rearrangement, B-Lymphocyte
1
2015
6
0.470
Why?
Receptors, Antigen, B-Cell
1
2015
7
0.470
Why?
Tumor Microenvironment
4
2024
256
0.440
Why?
Humans
50
2025
52483
0.390
Why?
Plasmacytoma
3
2022
43
0.390
Why?
Cell Differentiation
1
2015
665
0.380
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
2012
11
0.380
Why?
Lymphoma, Mantle-Cell
1
2012
18
0.380
Why?
Carcinoembryonic Antigen
1
2011
13
0.360
Why?
Calcitonin
1
2011
30
0.360
Why?
Antigens, CD
1
2012
218
0.340
Why?
Middle Aged
20
2025
13028
0.330
Why?
Prognosis
9
2025
2099
0.320
Why?
Carcinoma
1
2011
138
0.320
Why?
Myogenin
1
2008
4
0.310
Why?
Muscle Fibers, Slow-Twitch
1
2008
12
0.310
Why?
Muscle Fibers, Fast-Twitch
1
2008
14
0.310
Why?
Paraproteinemias
2
2022
74
0.290
Why?
Gene Expression Profiling
4
2025
1105
0.280
Why?
Positron-Emission Tomography
3
2025
301
0.270
Why?
Antineoplastic Combined Chemotherapy Protocols
5
2024
1031
0.270
Why?
Neoplasms, Second Primary
2
2019
77
0.260
Why?
Aged
18
2025
10121
0.250
Why?
Female
23
2025
28171
0.240
Why?
Male
20
2025
26761
0.240
Why?
Treatment Outcome
10
2022
5422
0.230
Why?
Pancytopenia
3
2016
38
0.230
Why?
Diffusion Magnetic Resonance Imaging
1
2025
133
0.230
Why?
Gastrointestinal Neoplasms
1
2022
42
0.190
Why?
Embolization, Therapeutic
2
2021
88
0.190
Why?
Neoplasms, Plasma Cell
2
2020
37
0.190
Why?
Thrombocytopenia
1
2022
89
0.180
Why?
Cryosurgery
1
2021
36
0.180
Why?
Chromosome Deletion
2
2023
142
0.180
Why?
Skin Neoplasms
2
2016
505
0.170
Why?
Transplantation, Autologous
4
2024
488
0.160
Why?
Adult
11
2025
14161
0.160
Why?
Combined Modality Therapy
1
2021
639
0.160
Why?
Ploidies
1
2018
10
0.150
Why?
Phenotype
2
2025
789
0.140
Why?
Hematopoietic Stem Cells
1
2019
187
0.140
Why?
Kidney Diseases
1
2020
220
0.140
Why?
Leukemia, Myeloid, Acute
1
2019
203
0.140
Why?
Herpesvirus 8, Human
1
2019
98
0.140
Why?
Sarcoma, Myeloid
1
2017
20
0.140
Why?
Chromosomes, Human, Pair 17
1
2017
35
0.140
Why?
Immunohistochemistry
3
2016
979
0.140
Why?
Lymph Nodes
2
2019
258
0.130
Why?
Amyloidosis
2
2016
85
0.130
Why?
Cell Cycle
1
2018
230
0.130
Why?
CA-125 Antigen
1
2016
16
0.130
Why?
Registries
3
2025
581
0.130
Why?
Disease Progression
4
2025
871
0.130
Why?
Skin Diseases, Infectious
1
2016
7
0.130
Why?
Leukemia, Promyelocytic, Acute
1
2016
12
0.130
Why?
Anemia, Aplastic
1
2016
11
0.130
Why?
Myeloproliferative Disorders
1
2016
31
0.120
Why?
Electrophoresis, Capillary
1
2015
10
0.120
Why?
In Situ Hybridization
1
2015
64
0.120
Why?
Tumor Suppressor Protein p53
1
2017
221
0.120
Why?
V(D)J Recombination
1
2015
4
0.120
Why?
Immunophenotyping
1
2015
117
0.120
Why?
Diagnosis, Differential
3
2016
1046
0.120
Why?
RNA, Messenger
2
2015
1132
0.120
Why?
Fatal Outcome
1
2015
197
0.120
Why?
Bone Marrow Transplantation
2
2022
113
0.110
Why?
Prealbumin
1
2014
22
0.110
Why?
Immunoglobulin Light Chains
1
2015
90
0.110
Why?
Bone Marrow Neoplasms
1
2014
13
0.110
Why?
Neoplasm Proteins
1
2016
334
0.110
Why?
Aged, 80 and over
5
2025
3392
0.110
Why?
Polymerase Chain Reaction
1
2015
461
0.110
Why?
Hodgkin Disease
1
2014
49
0.110
Why?
Parvoviridae Infections
1
2013
20
0.100
Why?
Parvovirus B19, Human
1
2013
17
0.100
Why?
Partial Thromboplastin Time
1
2012
13
0.100
Why?
Prothrombin Time
1
2012
18
0.100
Why?
Retrospective Studies
5
2025
6607
0.100
Why?
Afibrinogenemia
1
2012
5
0.100
Why?
Cardiomyopathies
1
2014
121
0.100
Why?
Immunoglobulins, Intravenous
1
2013
63
0.100
Why?
Predictive Value of Tests
1
2015
944
0.100
Why?
Plasma Exchange
1
2012
25
0.100
Why?
Retroperitoneal Neoplasms
1
2012
18
0.100
Why?
Glycoproteins
1
2012
122
0.100
Why?
Gene Expression Regulation, Neoplastic
1
2016
857
0.100
Why?
Precursor Cells, B-Lymphoid
1
2012
8
0.100
Why?
Histoplasma
1
2011
24
0.090
Why?
Antigens, Fungal
1
2011
20
0.090
Why?
Longitudinal Studies
2
2024
747
0.090
Why?
Immunoenzyme Techniques
1
2011
137
0.090
Why?
Hepatitis C
1
2012
79
0.090
Why?
Histoplasmosis
1
2011
47
0.090
Why?
Carcinoma, Neuroendocrine
1
2011
25
0.090
Why?
In Situ Hybridization, Fluorescence
3
2023
263
0.090
Why?
Dose-Response Relationship, Drug
2
2016
1378
0.080
Why?
Splenic Neoplasms
1
2009
2
0.080
Why?
Gene Expression
1
2012
618
0.080
Why?
Thyroid Neoplasms
1
2011
116
0.080
Why?
Myelodysplastic Syndromes
1
2009
86
0.080
Why?
Mutagenesis, Site-Directed
1
2008
95
0.080
Why?
Hemangioma
1
2009
84
0.070
Why?
Tomography, X-Ray Computed
3
2023
1165
0.070
Why?
HIV Infections
1
2012
389
0.070
Why?
Survival Analysis
2
2021
673
0.070
Why?
Cells, Cultured
2
2008
1567
0.070
Why?
Protein Processing, Post-Translational
1
2008
153
0.070
Why?
Stem Cell Transplantation
2
2022
185
0.070
Why?
Graft vs Host Disease
1
2007
87
0.070
Why?
Adolescent
2
2025
6739
0.070
Why?
Muscle Proteins
1
2008
321
0.060
Why?
Calcium-Calmodulin-Dependent Protein Kinases
1
2005
34
0.060
Why?
Semaphorin-3A
1
2004
2
0.060
Why?
p38 Mitogen-Activated Protein Kinases
1
2005
94
0.060
Why?
Nerve Degeneration
1
2004
24
0.060
Why?
Acid Anhydride Hydrolases
1
2004
14
0.060
Why?
Mitogen-Activated Protein Kinase 3
1
2004
49
0.060
Why?
Mitogen-Activated Protein Kinase 1
1
2004
50
0.060
Why?
ROC Curve
1
2025
253
0.060
Why?
Antineoplastic Agents
1
2013
1222
0.060
Why?
Imidazoles
1
2005
124
0.060
Why?
Muscle, Smooth, Vascular
1
2005
133
0.060
Why?
Ferritins
1
2024
36
0.050
Why?
Killer Cells, Natural
1
2024
116
0.050
Why?
Pyridines
1
2005
132
0.050
Why?
Gene Expression Regulation
1
2008
990
0.050
Why?
Myeloid Progenitor Cells
1
2023
17
0.050
Why?
Pyrimidines
1
2005
199
0.050
Why?
Cost of Illness
1
2024
121
0.050
Why?
CD8-Positive T-Lymphocytes
1
2024
132
0.050
Why?
Enzyme Inhibitors
1
2005
372
0.050
Why?
Adrenal Cortex Hormones
1
2023
116
0.050
Why?
Hippocampus
1
2004
201
0.050
Why?
Chromosomes, Human, Pair 1
1
2023
96
0.050
Why?
Case-Control Studies
2
2019
1201
0.050
Why?
Transcriptome
1
2025
370
0.050
Why?
Cohort Studies
2
2020
1542
0.050
Why?
Chromosome Aberrations
1
2023
297
0.050
Why?
Dexamethasone
1
2024
438
0.050
Why?
Mediastinum
1
2021
21
0.050
Why?
Gastrointestinal Tract
1
2022
108
0.050
Why?
Fever
1
2022
112
0.050
Why?
Neurons
1
2004
418
0.050
Why?
Vincristine
1
2021
88
0.050
Why?
T-Lymphocytes
1
2023
340
0.050
Why?
Axilla
1
2021
92
0.050
Why?
Prednisone
1
2021
102
0.040
Why?
Pelvis
1
2021
69
0.040
Why?
Time Factors
2
2017
2968
0.040
Why?
Cyclophosphamide
1
2021
171
0.040
Why?
Radiopharmaceuticals
1
2021
204
0.040
Why?
Signal Transduction
2
2004
1671
0.040
Why?
Alzheimer Disease
1
2004
332
0.040
Why?
Fluorodeoxyglucose F18
1
2021
188
0.040
Why?
Tumor Burden
1
2020
136
0.040
Why?
Mice
3
2023
5949
0.040
Why?
Doxorubicin
1
2021
241
0.040
Why?
Antibodies, Monoclonal
1
2023
481
0.040
Why?
False Negative Reactions
1
2019
30
0.040
Why?
Hospitalization
1
2024
736
0.040
Why?
Cell Line, Tumor
1
2023
1470
0.040
Why?
Herpesvirus 4, Human
1
2019
43
0.040
Why?
Epstein-Barr Virus Infections
1
2019
32
0.040
Why?
Phosphorylation
3
2005
528
0.040
Why?
Herpesviridae Infections
1
2019
57
0.040
Why?
Genome, Viral
1
2019
83
0.040
Why?
DNA, Viral
1
2019
137
0.040
Why?
Virus Diseases
1
2019
46
0.040
Why?
Follow-Up Studies
1
2024
2279
0.040
Why?
Neoplasm Recurrence, Local
1
2022
649
0.040
Why?
Liver
1
2022
1156
0.030
Why?
Scleromyxedema
1
2016
4
0.030
Why?
Schnitzler Syndrome
1
2016
4
0.030
Why?
Cryoglobulinemia
1
2016
13
0.030
Why?
Xanthomatosis
1
2016
10
0.030
Why?
Asymptomatic Diseases
1
2016
38
0.030
Why?
POEMS Syndrome
1
2016
34
0.030
Why?
Melphalan
1
2016
181
0.030
Why?
Disease-Free Survival
1
2016
460
0.030
Why?
Young Adult
1
2025
4329
0.030
Why?
Animals
3
2023
13505
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2015
185
0.030
Why?
Reed-Sternberg Cells
1
2014
2
0.030
Why?
HIV Seronegativity
1
2014
3
0.030
Why?
Karyotype
1
2014
19
0.030
Why?
Thalidomide
1
2016
377
0.030
Why?
Fusion Proteins, bcr-abl
1
2014
20
0.030
Why?
Cell Division
2
2005
291
0.030
Why?
Heterozygote
1
2014
90
0.030
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
2014
45
0.030
Why?
Mutation
1
2019
1347
0.030
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2015
582
0.030
Why?
Oligonucleotide Array Sequence Analysis
1
2015
405
0.030
Why?
Remission Induction
1
2014
218
0.030
Why?
Fibrinogen
1
2012
34
0.030
Why?
Blood Coagulation
1
2012
64
0.020
Why?
Risk Assessment
1
2017
1327
0.020
Why?
Survival Rate
1
2015
945
0.020
Why?
Neoplasm Staging
1
2015
772
0.020
Why?
Reference Values
1
2012
313
0.020
Why?
Biopsy
1
2014
605
0.020
Why?
Antibodies, Fungal
1
2011
2
0.020
Why?
Mycological Typing Techniques
1
2011
3
0.020
Why?
Cross Reactions
1
2011
41
0.020
Why?
Lung Diseases, Fungal
1
2011
20
0.020
Why?
Immunocompromised Host
1
2011
123
0.020
Why?
Splenectomy
1
2009
36
0.020
Why?
Severity of Illness Index
1
2012
1026
0.020
Why?
Sensitivity and Specificity
1
2011
891
0.020
Why?
Blood Transfusion
1
2009
127
0.020
Why?
Transplantation, Isogeneic
1
2007
2
0.020
Why?
Laparoscopy
1
2009
180
0.020
Why?
Mice, Inbred C3H
1
2007
83
0.020
Why?
Cyclosporine
1
2007
67
0.020
Why?
Mice, SCID
1
2007
182
0.020
Why?
Magnetic Resonance Imaging
1
2014
1546
0.020
Why?
Models, Animal
1
2007
234
0.020
Why?
Immunosuppressive Agents
1
2007
243
0.010
Why?
Macromolecular Substances
1
2004
31
0.010
Why?
Physical Chromosome Mapping
1
2004
8
0.010
Why?
tau Proteins
1
2004
27
0.010
Why?
Genetic Complementation Test
1
2004
47
0.010
Why?
Epitopes
1
2004
65
0.010
Why?
Epidermal Growth Factor
1
2004
36
0.010
Why?
Microtubule-Associated Proteins
1
2004
65
0.010
Why?
Catalytic Domain
1
2004
60
0.010
Why?
Cricetulus
1
2004
104
0.010
Why?
Mutagenesis
1
2004
61
0.010
Why?
Cricetinae
1
2004
194
0.010
Why?
Cloning, Molecular
1
2004
190
0.010
Why?
Intercellular Signaling Peptides and Proteins
1
2004
105
0.010
Why?
Receptors, Cell Surface
1
2004
118
0.010
Why?
RNA
1
2004
168
0.010
Why?
Amino Acid Sequence
1
2004
578
0.010
Why?
Cell Survival
1
2005
612
0.010
Why?
Molecular Sequence Data
1
2004
778
0.010
Why?
Nerve Tissue Proteins
1
2004
187
0.010
Why?
Mice, Inbred C57BL
1
2007
1884
0.010
Why?
Cell Line
1
2004
1030
0.010
Why?
Alapat's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description